Alpha Centric Advisors LLC Abbott Laboratories Transaction History
Alpha Centric Advisors LLC
- $97.4 Million
- Q4 2024
A detailed history of Alpha Centric Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 9,333 shares of ABT stock, worth $1.19 Million. This represents 1.08% of its overall portfolio holdings.
Number of Shares
9,333Holding current value
$1.19 Million% of portfolio
1.08%Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,608Shares Held
1.4BCall Options Held
9.22MPut Options Held
8.09M-
Vanguard Group Inc Valley Forge, PA173MShares$22 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$9.97 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$7.65 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.31 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $223B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...